Palliative Sedation Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Palliative Sedation. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Palliative Sedation Indian Medical PG Question 1: What is the definition of conscious sedation?
- A. CNS depression with unconsciousness
- B. Sedation with inability to respond to verbal commands
- C. Sedation with ability to respond to verbal commands (Correct Answer)
- D. None of the options
Palliative Sedation Explanation: ***Sedation with ability to respond to verbal commands***
- Conscious sedation involves a drug-induced depression of consciousness during which the patient **retains the ability to respond purposefully to verbal commands**.
- This level of sedation ensures that the patient's **airway reflexes** and **ventilatory function** remain intact.
*CNS depression with unconsciousness*
- This describes **general anesthesia** or **deep sedation**, where the patient is unable to respond purposefully to verbal commands.
- In such states, spontaneous ventilation may be **inadequate**, and **airway support** is often required.
*Sedation with inability to respond to verbal commands*
- This definition aligns with **deep sedation** or **general anesthesia**, where the patient's consciousness is significantly depressed.
- At this level, patients may require assistance in maintaining a **patent airway** and adequate ventilation.
*None of the options*
- This option is incorrect because one of the provided definitions accurately describes conscious sedation.
- The definition of conscious sedation is well-established in clinical practice, emphasizing the **preservation of responsiveness**.
Palliative Sedation Indian Medical PG Question 2: Best guide for the management of Resuscitation is:
- A. Saturation of Oxygen
- B. CVP
- C. Blood pressure
- D. Urine output (Correct Answer)
Palliative Sedation Explanation: ***Urine output***
- **Urine output** is considered the **gold standard** for assessing adequacy of resuscitation as it directly reflects **end-organ perfusion** and **tissue oxygenation**. A target of **0.5-1 mL/kg/hour** indicates adequate renal perfusion and overall circulatory status.
- It serves as a reliable **endpoint of resuscitation** in trauma and critical care protocols, providing objective evidence that fluid resuscitation has achieved adequate **tissue perfusion** and **microcirculatory flow**.
*Saturation of Oxygen*
- While **oxygen saturation** is crucial for ensuring adequate **oxygen delivery** to tissues, it represents only one component of the oxygen delivery equation and doesn't reflect **tissue perfusion** adequacy.
- Maintaining normal oxygen saturation does not guarantee adequate **end-organ perfusion** if cardiac output or tissue perfusion is compromised during resuscitation.
*CVP*
- **Central venous pressure** has poor correlation with actual **intravascular volume status** and **cardiac preload**, making it an unreliable guide for fluid resuscitation.
- CVP measurements are influenced by multiple factors including **ventilator settings**, **tricuspid valve function**, and **chest wall compliance**, limiting its utility as a resuscitation endpoint.
*Blood pressure*
- While **blood pressure** provides immediate feedback on **circulatory status** and is emphasized in current **ACLS** and **ATLS** protocols as an immediate target, it may not accurately reflect **microcirculatory perfusion**.
- Blood pressure can be maintained through **vasoconstriction** while **end-organ perfusion** remains inadequate, making it less reliable than urine output for assessing true resuscitation adequacy.
Palliative Sedation Indian Medical PG Question 3: What is the drug of choice for treating delirium tremens?
- A. Phenytoin
- B. Morphine
- C. Lorazepam (Correct Answer)
- D. Diazepam
Palliative Sedation Explanation: ***Lorazepam***
- **Benzodiazepines** are the first-line treatment for **delirium tremens** due to their effectiveness in reducing central nervous system hyperexcitability through GABA-A receptor agonism.
- **Lorazepam** is often preferred, especially in patients with liver impairment (common in chronic alcoholics), because it is metabolized by **glucuronidation** rather than hepatic oxidation, making it safer in hepatic dysfunction.
- It has an **intermediate half-life (10-20 hours)** with **no active metabolites**, providing predictable pharmacokinetics and easier dose titration.
- Can be administered via multiple routes (IV, IM, oral), making it versatile in acute settings.
*Diazepam*
- Also a **first-line benzodiazepine** for alcohol withdrawal and delirium tremens, particularly effective in patients with normal liver function.
- Has a **long half-life (20-100 hours)** with **active metabolites** (desmethyldiazepam), which can accumulate in patients with hepatic impairment, leading to prolonged sedation.
- Metabolized by hepatic **oxidation** (CYP450), making it less ideal in liver disease.
- The longer duration of action can be advantageous for tapering protocols but may cause excessive sedation in vulnerable patients.
*Phenytoin*
- **Phenytoin** is an **anticonvulsant** that is **not effective** for treating delirium tremens or alcohol withdrawal seizures as monotherapy.
- It does not address the primary pathophysiology of alcohol withdrawal, which involves GABAergic and glutamatergic system imbalance.
- May be used as **adjunctive therapy** in patients with concurrent seizure disorders, but benzodiazepines remain the mainstay.
*Morphine*
- **Morphine** is an **opioid analgesic** with **no role** in the treatment of delirium tremens.
- Use of opioids could **worsen respiratory depression**, particularly dangerous in agitated patients with potential for aspiration.
- Does not address the neurochemical basis of alcohol withdrawal and may complicate management.
Palliative Sedation Indian Medical PG Question 4: Which anxiolytic acts through 5-HT1A receptor partial agonism without exhibiting significant anticonvulsant or muscle relaxant properties?
- A. Diazepam
- B. Zolpidem
- C. Phenobarbitone
- D. Buspirone (Correct Answer)
Palliative Sedation Explanation: ***Buspirone***
- **Buspirone** is a unique anxiolytic that primarily acts as a **partial agonist at 5-HT1A receptors**.
- Unlike benzodiazepines, it lacks significant **anticonvulsant**, **muscle relaxant**, or **sedative-hypnotic properties** and does not lead to physical dependence or withdrawal.
*Diazepam*
- **Diazepam** is a **benzodiazepine** that acts by enhancing the effect of **GABA** at GABA-A receptors, leading to significant anxiolytic, sedative, muscle relaxant, and anticonvulsant effects.
- It does not primarily act via **5-HT1A receptor partial agonism**.
*Zolpidem*
- **Zolpidem** is a **non-benzodiazepine hypnotic** that selectively binds to the **GABA-A receptor** subunit, primarily mediating sedative effects.
- While it's used for insomnia, it doesn't primarily act as a **5-HT1A partial agonist** and is not typically used for its anxiolytic properties in the same way as buspirone.
*Phenobarbitone*
- **Phenobarbitone** is a **barbiturate** that acts by prolonging the opening of **chloride channels** associated with GABA-A receptors, leading to strong sedative, hypnotic, and anticonvulsant effects.
- Its mechanism of action is distinct from **5-HT1A receptor partial agonism**, and it carries a high risk of dependence and overdose.
Palliative Sedation Indian Medical PG Question 5: Which of the following statements about flumazenil is correct?
- A. Can be used in barbiturate poisoning
- B. Specific antidote for opiate overdose
- C. Can be used in benzodiazepine overdose (Correct Answer)
- D. None of the options
Palliative Sedation Explanation: ***Can be used in benzodiazepine overdose***
- **Flumazenil** is a **competitive antagonist** at the **GABA-A receptor**, specifically designed to reverse the effects of **benzodiazepines**.
- It binds to the same receptor site as benzodiazepines, effectively blocking their sedative and anxiolytic actions, making it useful in emergent overdose situations.
*Can be used in barbiturate poisoning*
- **Flumazenil** is **ineffective** in **barbiturate overdose** because barbiturates bind to a different site on the GABA-A receptor than benzodiazepines.
- Barbiturates enhance **GABAergic activity** through a distinct mechanism, which flumazenil does not antagonize.
*Specific antidote for opiate overdose*
- The **specific antidote for opiate overdose** is **naloxone**, which acts as an opioid receptor antagonist.
- **Flumazenil** has **no affinity** for opioid receptors and thus no role in reversing opiate toxicity.
*None of the options*
- This option is incorrect because **flumazenil** is indeed used for **benzodiazepine overdose**, as described above.
- Its specific mechanism of action targets benzodiazepine-induced central nervous system depression.
Palliative Sedation Indian Medical PG Question 6: Which Benzodiazepine decreases post-operative nausea & vomiting:-
- A. Midazolam (Correct Answer)
- B. Diazepam
- C. Lorazepam
- D. All of the options
Palliative Sedation Explanation: ***Midazolam***
- **Midazolam** is a commonly used benzodiazepine in anesthesia that has been shown to have **antiemetic properties** and can decrease the incidence of **postoperative nausea and vomiting (PONV)**.
- Its mechanism may involve its sedative and anxiolytic effects, indirectly reducing the triggers for nausea.
*Diazepam*
- While **diazepam** is a benzodiazepine with sedative and anxiolytic effects, it is not primarily known for reducing PONV.
- Its longer duration of action compared to midazolam can also contribute to unwanted **postoperative sedation**.
*Lorazepam*
- **Lorazepam** is another benzodiazepine used for anxiolysis and sedation but is not a primary agent for the prevention of PONV.
- Like diazepam, its prolonged effects can lead to **delayed recovery** and drowsiness, which may not be desirable in the postoperative period.
*All of the options*
- While all listed drugs are benzodiazepines, only **midazolam** is consistently recognized and utilized for its ability to reduce PONV in the perioperative setting.
- The other benzodiazepines do not demonstrate the same consistent benefit in PONV reduction and may have other side effects that limit their utility for this specific purpose.
Palliative Sedation Indian Medical PG Question 7: The following procedures are recommended for palliation in a patient with obstructive jaundice due to unresectable carcinoma of head of pancreas except:
- A. Cholecystojejunostomy with jejunojejunostomy with gastrojejunostomy
- B. Hepaticojejunostomy with gastrojejunostomy
- C. Choledochoduodenostomy with gastrojejunostomy
- D. Choledochoduodenostomy, gastrojejunostomy with pancreaticojejunostomy (Correct Answer)
Palliative Sedation Explanation: ***Choledochoduodenostomy, gastrojejunostomy with pancreaticojejunostomy***
- **Pancreaticojejunostomy is NOT indicated** in palliative surgery for unresectable pancreatic cancer.
- This procedure is used to anastomose the **pancreatic remnant** after **resection** (as in Whipple procedure), not in bypass operations.
- Palliation focuses on **relieving biliary and gastric outlet obstruction** without performing pancreatic anastomosis, making this combination inappropriate for palliative care.
*Cholecystojejunostomy with jejunojejunostomy with gastrojejunostomy*
- **Cholecystojejunostomy** diverts bile flow from the gallbladder to the jejunum, relieving biliary obstruction when the cystic duct is patent.
- **Gastrojejunostomy** relieves gastric outlet obstruction, a common complication of pancreatic head cancer.
- This represents a valid **triple bypass** palliative approach.
*Hepaticojejunostomy with gastrojejunostomy*
- **Hepaticojejunostomy** creates a bypass between the common hepatic duct and the jejunum, effectively relieving biliary obstruction.
- **Gastrojejunostomy** manages or prevents gastric outlet obstruction.
- This **double bypass** is a standard palliative procedure for unresectable pancreatic head cancer.
*Choledochoduodenostomy with gastrojejunostomy*
- **Choledochoduodenostomy** directly bypasses the biliary obstruction by connecting the common bile duct to the duodenum.
- **Gastrojejunostomy** addresses gastric outlet obstruction from duodenal compression by the tumor.
- This **double bypass** is another widely accepted palliative approach.
Palliative Sedation Indian Medical PG Question 8: A 68-year-old man with terminal lung cancer develops confusion, myoclonus, and hallucinations after being on high-dose morphine (240 mg/day oral) for 2 weeks. His renal function shows creatinine 2.8 mg/dL. What is the most appropriate management considering the pathophysiology?
- A. Continue morphine but add naloxone infusion
- B. Add haloperidol for delirium and continue morphine
- C. Switch to fentanyl as it has no active metabolites and dose adjust for renal function (Correct Answer)
- D. Stop all opioids and use only adjuvant analgesics
Palliative Sedation Explanation: ***Switch to fentanyl as it has no active metabolites and dose adjust for renal function***
- The patient is experiencing **opioid-induced neurotoxicity (OIN)** due to the accumulation of morphine metabolites, specifically **Morphine-3-glucuronide (M3G)** and **Morphine-6-glucuronide (M6G)**, which are cleared renally.
- **Fentanyl** is the preferred opioid in renal impairment because it has no clinically significant active metabolites and does not undergo significant renal excretion [1].
*Continue morphine but add naloxone infusion*
- Adding **naloxone** would reverse the analgesic effects and likely precipitate an acute **withdrawal syndrome** or uncontrolled cancer pain.
- This does not address the underlying cause, which is the accumulation of **neuroexcitatory metabolites** in the setting of renal failure.
*Add haloperidol for delirium and continue morphine*
- **Haloperidol** may mask the symptoms of delirium but does not stop the progression of **myoclonus** or neurotoxicity caused by toxic metabolites.
- Continuing morphine in a patient with a **creatinine of 2.8 mg/dL** will lead to further metabolite accumulation and potential seizures.
*Stop all opioids and use only adjuvant analgesics*
- Abruptly stopping opioids in a patient on a high dose (240 mg/day) will lead to severe **withdrawal** and a massive **pain crisis**.
- Terminal lung cancer pain requires effective opioid management; switching to a safer agent (opioid rotation) is the standard of care rather than complete discontinuation [1].
Palliative Sedation Indian Medical PG Question 9: A 62-year-old woman with advanced ovarian cancer has been on oral morphine 90 mg BD for 3 months. She now reports reduced pain relief despite increasing doses, but experiences severe pain at specific sites of bone metastases. What is the best management strategy?
- A. Add ketamine infusion for opioid resistance
- B. Switch to fentanyl patch and continue dose escalation
- C. Add gabapentin and consider palliative radiotherapy to metastatic sites (Correct Answer)
- D. Rotate to hydromorphone at equianalgesic dose
Palliative Sedation Explanation: ***Add gabapentin and consider palliative radiotherapy to metastatic sites***
- Bone metastases often cause **neuropathic pain** and inflammatory response; adding a **gabapentinoid** treats the nerve-related component that opioids may not fully cover [1].
- **Palliative radiotherapy** is highly effective for localized bone pain, often allowing for **reduced opioid requirements** and improved quality of life.
*Add ketamine infusion for opioid resistance*
- While **ketamine** is an NMDA antagonist used for refractory pain, it is generally reserved for specialists when common adjuncts and localized treatments fail.
- It is a more invasive and complex intervention compared to **radiotherapy** and oral adjuvants like **gabapentin** for focal bone pain.
*Switch to fentanyl patch and continue dose escalation*
- Increasing the dose of a different opioid (dose escalation) is unlikely to resolve **opioid-insensitive** bone pain and may increase the risk of **opioid-induced hyperalgesia** [2].
- Transdermal **fentanyl** is more suitable for stable pain control and does not address the localized, metastatic nature of the patient's pain [1].
*Rotate to hydromorphone at equianalgesic dose*
- **Opioid rotation** to hydromorphone is helpful if the patient is experiencing side effects, but it does not address the underlying pathology of **bone metastases** [1].
- Rotation alone does not provide the specific **neuropathic** or **anti-tumor** benefits offered by the combination of gabapentin and radiotherapy.
Palliative Sedation Indian Medical PG Question 10: A 55-year-old man with terminal esophageal cancer develops respiratory secretions causing death rattle. Despite positioning and suctioning, the symptom persists. Which medication would be most appropriate and why?
- A. Morphine - reduces respiratory drive and secretions
- B. Hyoscine butylbromide - antimuscarinic action reduces secretions without sedation (Correct Answer)
- C. Midazolam - sedates patient reducing awareness of secretions
- D. Furosemide - reduces fluid overload causing secretions
Palliative Sedation Explanation: Hyoscine butylbromide - antimuscarinic action reduces secretions without sedation
- **Hyoscine butylbromide** is the preferred medication for the **death rattle** because its **antimuscarinic properties** effectively dry up salivary and bronchial secretions.
- Unlike hyoscine hydrobromide, it does not cross the **blood-brain barrier**, meaning it reduces secretions with minimal risk of **sedation** or **delirium**.
*Morphine - reduces respiratory drive and secretions*
- While **morphine** is excellent for managing **dyspnea** and pain at the end of life, it does not possess **antisecretory** properties to manage a death rattle [1].
- Overuse of opioids for secretions can lead to unnecessary **respiratory depression** or decreased level of consciousness without fixing the noisy breathing.
*Midazolam - sedates patient reducing awareness of secretions*
- **Midazolam** is a benzodiazepine used for **terminal agitation** or anxiety but does not affect the production of **respiratory secretions**.
- Although it might reduce patient awareness, it does not address the **audible noise** which is often distressing for the family members observing the patient [2].
*Furosemide - reduces fluid overload causing secretions*
- **Furosemide** is indicated for **pulmonary edema** caused by congestive heart failure, not for the terminal accumulation of oropharyngeal secretions.
- Using diuretics in a terminal patient with a death rattle is generally **ineffective** as the noise is caused by pooled saliva rather than **systemic fluid overload**.
More Palliative Sedation Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
